Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 2227384-17-8
2. Gnr4jzg668
3. Cvl354
4. Cvl-354
5. Pf06874354
6. Pf-06874354
7. Refchem:1087136
8. Icalcaprant [inn]
9. Icalcaprant (usan/inn)
10. Icalcaprant [usan]
11. Orb2277626
12. Chembl5314519
13. Schembl20187287
14. Da-64356
15. Hy-156614
16. Cs-0886230
17. D13002
18. 4-(4-{[(2s)-2-(3-methoxy-1-methyl-1h-pyrazol-4-yl)pyrrolidin-1-yl]methyl}phenoxy)benzamide
19. Benzamide, 4-[4-[[(2s)-2-(3-methoxy-1-methyl-1h-pyrazol-4-yl)-1-pyrrolidinyl] Methyl]phenoxy]-
| Molecular Weight | 406.5 g/mol |
|---|---|
| Molecular Formula | C23H26N4O3 |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 82.6 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 561 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE